The three-month opioid treatment retention rate for a rural telemedicine mobile treatment unit (TM-MTU) plus buprenorphine was not statistically different to the retention rate for office-based treatment. The three-month retention rate for the MTU was 58.5%. In comparison, the three-month retention rate for those in an evaluation of both TM-MTU and non-TM-MTU treatment was approximately 75.4%. Longer retention was significantly associated with reduced opioid use.

Opioid use for those in TM-MTU dropped by about 32.8% from baseline. Compared with the nearest in-person treatment location, the telemedicine TM . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.